Cargando…
A Preclinical Investigation on the Role of IgG Antibodies against Coagulant Components in Multiple Sclerosis
The coagulation-inflammation interplay has recently been identified as a critical risk factor in the early onset of multiple sclerosis (MS), and antibodies against coagulation components have been recognized as contributing factors to thrombotic and inflammatory signaling pathways in diseases with o...
Autores principales: | Hadjiagapiou, Maria S., Krashias, George, Deeba, Elie, Christodoulou, Christina, Pantzaris, Marios, Lambrianides, Anastasia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046059/ https://www.ncbi.nlm.nih.gov/pubmed/36979885 http://dx.doi.org/10.3390/biomedicines11030906 |
Ejemplares similares
-
SARS-CoV-2-specific antibody responses following BNT162b2 vaccination in individuals with multiple sclerosis receiving different disease-modifying treatments
por: Lambrianides, Anastasia, et al.
Publicado: (2023) -
Genetic Markers for Thrombophilia and Cardiovascular Disease Associated with Multiple Sclerosis
por: Hadjiagapiou, Maria S., et al.
Publicado: (2022) -
The expression profile of virus-recognizing toll-like receptors in natural killer cells of Cypriot multiple sclerosis patients
por: Deeba, Elie, et al.
Publicado: (2020) -
Serum Reactive Antibodies against the N-Methyl-D-Aspartate Receptor NR2 Subunit—Could They Act as Potential Biomarkers?
por: Hadjiagapiou, Maria S., et al.
Publicado: (2023) -
SARS CoV- 2 vaccination induces antibodies against cardiolipin
por: Krashias, George, et al.
Publicado: (2022)